These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2702793)

  • 1. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Scavone JM; Tai NT; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1989 Jul; 250(1):134-40. PubMed ID: 2746493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
    Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
    Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam.
    Bührer M; Maitre PO; Crevoisier C; Stanski DR
    Clin Pharmacol Ther; 1990 Nov; 48(5):555-67. PubMed ID: 2225714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
    Ebert U; Oertel R; Kirch W
    Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
    Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
    Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time.
    Friedman H; Greenblatt DJ; Peters GR; Metzler CM; Charlton MD; Harmatz JS; Antal EJ; Sanborn EC; Francom SF
    Clin Pharmacol Ther; 1992 Aug; 52(2):139-50. PubMed ID: 1505149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of midazolam in a modified NLA--study on plasma concentrations].
    Nishiyama T; Ueno T; Taga N; Iwado S; Yaida Y; Morita K; Kosaka F
    Masui; 1989 Aug; 38(8):1048-53. PubMed ID: 2810699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cerebral pharmacokinetics and pharmacodynamics of diazepam and midazolam after short intravenous infusion administration in sheep.
    Upton RN; Ludbrook GL; Grant C; Martinez A
    J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):129-53. PubMed ID: 11381567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative absorption kinetics of intramuscular midazolam and diazepam.
    Hung OR; Dyck JB; Varvel J; Shafer SL; Stanski DR
    Can J Anaesth; 1996 May; 43(5 Pt 1):450-5. PubMed ID: 8723850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.